Live Quote · NASDAQDNTHHealthcare· Biotechnology

Dianthus Therapeutics, Inc.

$84.55▼ 0.33%($-0.28)
MKT CAP $4.76BNEXT EARNINGS Mar 8, 2027
50%
Bullish
TickerSpark Score
39/100
▌ Weak
32
Valuation
40
Profitability
10
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DNTH research report →

Analyst Price Target
$136.50+61.4% vs. today

Range $122 – $158

Analyst RatingBuy
11 Buy0 Hold0 Sell

Price Chart

+107.97% · this period
$115.96$76.08$36.20Nov 19May 22Nov 19
52-Week Range59% of range
Low
$35.84
Current
$84.55
High
$117.88